Description
Tecentriq is used in the treatment of Hepatocellular Carcinoma; Small Cell Lung Cancer; Alveolar Soft Part Sarcoma; Non-Small Cell Lung Cancer; and Melanoma and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors).
- Tecentriq 1200 mg/20 mL solution for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
How to use:
- Tecentriq 1200mg Injection is given as an injection into veins under the supervision of a doctor.
- Your doctor will decide what dose is necessary and how often you need to take it.
- This will depend on what you are being treated for and may change from time to time.
Caution & Warnings:
- Black, tarry stools
- Bladder pain
- Bloating or swelling of the face, arms, hands, lower legs, or feet
- Bloody or cloudy urine
- Blurred vision
- Body aches or pain
- Chest tightness, chills
- Constipation
- Cough
- Diarrhea
- Difficult, burning, or painful urination
- Difficulty in breathing
- Dizziness
- Ear congestion, fever
- Frequent urge to urinate
- General feeling of tiredness and weakness, headache
- Hoarseness
- Loss of appetite
- Loss of voice, pale skin
Ingredients:
- Atezolizumab1200 mg/20 mL.
Reviews
There are no reviews yet.